Mostrando 9 resultados de: 9
Publisher
Nature Microbiology(2)
BMC Infectious Diseases(1)
Cell Reports(1)
Nature(1)
Nature Communications(1)
Área temáticas
Medicina forense; incidencia de enfermedades(7)
Enfermedades(5)
Medicina y salud(4)
Microorganismos, hongos y algas(4)
Fisiología humana(2)
Origen
scopus(9)
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
ArticleAbstract: Background: The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in England. We aiPalabras claves:Autores:Aanensen D.M., Abudahab K., Adams H., Afifi S., Antonelli M., Ash A., Batra R., Beckett A.H., Beer R., Bernardo M. Gutierrez, Berry L., Bird P.W., Blakey V., Bonsall D., Boswell T., Bresner C., Campbell S., Canas L.S., Capdevila J., Carlile M., Charalampous T., Clark G., Cogger B.J., Coll F., Connor T.R., Cortes N., Curran T., Debebe J., Drew D.A., Edgeworth J., Fairley D.J., Fallon K., Fleming V.M., Fraser C., Fuller W., Golubchik T., Graham M.S., Guest M., Gulliver H., Hassan-Ibrahim M.O., Helmer T., Holmes C., Holmes N., Howson-Wells H.C., Hu C., John M., Jones C., Joseph A., Khakh M., Kidd S., Kitchen C., Kläser K., Koshy C., Lister M.M., Loose M.W., Lynch J., Maksimovic J., Malone C.S., Marchbank A., May A., McCluggage K., McKenna J.P., Menegazzo M., Merrick I., Modat M., Molteni E., Moore C., Moore N., Morgan S., Mori M., Munn R., Murray B., Nebbia G., Nguyen L.H., Patel A., Polidori L., Price A., Raviprakash V., Reynolds N., Robson S.C., Sang F., Selvachandran S., Sheriff N., Signell A.W., Smith W., Snell L.B., Southgate J., Spellman K., Sudre C.H., Tang J., Taylor B.E.W., Underwood A.P., Varsavsky T., Wantoch M., Warne B., Williams L.A., Willingham I., Wise E.L., Workman T., Wright V., Yeats C.A.Fuentes:scopusAssessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
ArticleAbstract: The SARS-CoV-2 lineage B.1.1.7, designated variant of concern (VOC) 202012/01 by Public Health EnglaPalabras claves:Autores:Aanensen D.M., Abudahab K., Adams H., Afifi S., Amato R., Ariani C.V., Ash A., Barrett J.C., Batra R., Beckett A.H., Beer R., Bernardo M. Gutierrez, Berry L., Bird P.W., Bonsall D., Boswell T., Boyd O., Bresner C., Campbell S., Chand M., Charalampous T., Clark G., Cogger B.J., Connor T.R., Cortes N., Curran T., Dabrera G., Edgeworth J., Fairley D.J., Fallon K., Fleming V.M., Fraser C., Fuller W., Gaythorpe K., Geidelberg L., Golubchik T., Goncalves S., Groves N., Guest M., Gulliver H., Harrison I., Hassan-Ibrahim M.O., Helmer T., Hill V., Hinsley W.R., Holmes C., Howson-Wells H.C., Jackson B., Jackson D.K., John M., Johnson R., Jones C., Jorgensen D., Joseph A., Khakh M., Kidd S., Kitchen C., Koshy C., Kwiatkowski D.P., Laydon D.J., Lister M.M., Loman N.J., Lynch J., Maksimovic J., Malone C.S., Marchbank A., McCluggage K., McCrone J.T., McKenna J.P., Menegazzo M., Merrick I., Mishra S., Moore N., Morgan S., Mori M., Munn R., Myers R., Nebbia G., O’toole A., Patel A., Price A., Ragonnet-Cronin M., Raviprakash V., Reynolds N., Robson S.C., Sheriff N., Sillitoe J., Smith W., Snell L.B., Southgate J., Spellman K., Tang J., Taylor B.E.W., Underwood A.P., Volz E.M., Wantoch M., Warne B., Willingham I., Wise E.L., Workman T., Yeats C.A.Fuentes:scopusGenomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission
ArticleAbstract: Mitigation of SARS-CoV-2 transmission from international travel is a priority. We evaluated the effePalabras claves:Autores:Aanensen D.M., Abudahab K., Adams H., Afifi S., Aggarwal D., Ash A., Batra R., Beckett A.H., Beer R., Bernardo M. Gutierrez, Berry L., Bird P.W., Blakey V., Bonsall D., Boswell T., Bresner C., Campbell S., Carlile M., Charalampous T., Chen C., Clark G., Cogger B.J., Coll F., Connor T.R., Cortes N., Curran T., Debebe J., Edgeworth J., Ellaby N., Fairley D.J., Fallon K., Fleming V.M., Fraser C., Fuller W., Gallagher E., Golubchik T., Groves N., Guest M., Gulliver H., Harrison A., Hassan-Ibrahim M.O., Helmer T., Holmes C., Holmes N., Howson-Wells H.C., Hughes G.J., John M., Jones C., Joseph A., Khakh M., Kidd S., Kitchen C., Koshy C., Le Viet T., Lister M.M., Logan S., Loose M.W., Lynch J., Maksimovic J., Malone C.S., Marchbank A., McCluggage K., McKenna J.P., Menegazzo M., Merrick I., Moore C., Moore N., Morgan S., Mori M., Munn R., Myers R., Nebbia G., Page A.J., Patel A., Platt S., Price A., Raviprakash V., Reynolds N., Robson S.C., Sang F., Savva G.M., Schaefer U., Sheriff N., Smith W., Snell L.B., Southgate J., Spellman K., Tang J., Taylor B.E.W., Tumelty N.M., Turner C., Underwood A.P., Volz E.M., Wantoch M., Warne B., Williams L.A., Willingham I., Wise E.L., Workman T., Wright V., Yeats C.A.Fuentes:scopusGenomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning
ArticleAbstract: Whole genome sequencing of SARS-CoV-2 has occurred at an unprecedented scale, and can be exploited fPalabras claves:Autores:Aanensen D.M., Aggarwal D., Amato R., Ariani C.V., Barrett J.C., Bashton M., Beckett A.H., Beckwith S.M., Bernardo M. Gutierrez, Bonsall D., Bucca G., Bull M., Burns P.J., Byott M., Carabelli A.M., Carmichael S., Christofidis N., Connor T.R., Corden S., Cortes N., Cottrell S., Curran M.D., de Silva T.I., Eastick K., Enright J., Fairley D.J., Frampton D., Glaysher S., Goldstein E.J., Golubchik T., Goncalves S., Goodfellow I.G., Griffiths E., Gunson R.N., Hamilton W.L., Harrison E.M., Hassan-Ibrahim M.O., Holden M.T.G., Houlihan C., Hughes J., Jackson D.K., Jackson L.M., Johnston I., Kwiatkowski D.P., Langford C.F., Levett L.J., Liggett S., Lillie P.J., Livett R., Loman N.J., Loose M.W., Loveson K.F., Ludden C., Lythgoe K., Mahungu T.W., Moore C., Moore N., Moses S., Murray A., Nastouli E., Nebbia G., Nicholls S.M., Nickbakhsh S., Nomikou K., Nunez R.T.M., Orton R.J., Osman H., O’Grady J., Pacchiarini N., Palmalux N., Parker M.D., Parmar S., Pope C.F., Prieto J.A., Rambaut A., Randell P., Robson S.C., Rogan F., Saeed K., Shaaban S., Shepherd J.G., Sheridan L.A., Sillitoe J., Simpson D.A., Singleton D., Smith C.P., Smith D.L., Smollett K., Snell L.B., Sreenu V.B., Templeton K.E., Thomas C., Thomson E.C., Tomb R.M., Tong L., Torok M.E., Underwood A.P., Wang D., Watkins J., Williams C., Witney A.A.Fuentes:scopusHospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
ArticleAbstract: Background: The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March, 2021. IPalabras claves:Autores:Aanensen D.M., Abudahab K., Adams H., Afifi S., Aliabadi S., Ash A., Batra R., Beckett A.H., Beer R., Bernardo M. Gutierrez, Berry L., Betancor G., Bird P.W., Blakey V., Bonsall D., Boswell T., Bresner C., Campbell S., Carlile M., Charalampous T., Charlett A., Clark G., Cogger B.J., Coll F., Connor T.R., Cortes N., Curran T., Dabrera G., De Angelis D., Debebe J., Edgeworth J., Fairley D.J., Fallon K., Fleming V.M., Fraser C., Fuller W., Gallagher E., Golubchik T., Guest M., Gulliver H., Harris R.J., Hassan-Ibrahim M.O., Helmer T., Holmes C., Holmes N., Hope R., Howson-Wells H.C., John M., Jones C., Joseph A., Khakh M., Kidd S., Kitchen C., Koshy C., Lister M.M., Loose M.W., Lopez-Bernal J., Lynch J., Maksimovic J., Malone C.S., Marchbank A., McCluggage K., McKenna J.P., Menegazzo M., Merrick I., Moore C., Moore N., Morgan S., Mori M., Munn R., Nebbia G., Nyberg T., Patel A., Presanis A.M., Price A., Raviprakash V., Reynolds N., Robson S.C., Sang F., Seaman S.R., Sheriff N., Signell A.W., Sinnathamby M.A., Smith W., Snell L.B., Southgate J., Spellman K., Tang J., Taylor B.E.W., Thelwall S., Twohig K.A., Underwood A.P., Wantoch M., Warne B., Williams L.A., Willingham I., Wise E.L., Workman T., Wright V., Yeats C.A., Zaidi A.Fuentes:scopusRecurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
ArticleAbstract: We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70 in multiple inPalabras claves:Alpha variant, antibody escape, B.1.1.7, covid-19, deletion, infectivity, neutralizing antibodies, RESISTANCE, SARS-COV-2, spike mutationAutores:Aanensen D.M., Aggarwal D., Alderton A., Amato R., Andersson M.I., Ariani C.V., Awan A.R., Barrett J., Bashton M., Bassett A.R., Bernardo M. Gutierrez, Bonsall D., Bucca G., Bull M., Chand M., Chapman M.H.S., Chauhan A.J., Collier D.A., Connor T.R., Constantinidou C., Corden S., Cottrell S., Curran M.D., Darby A.C., Datir R.P., de Silva T.I., Dewar R., Elliott S., Fairley D.J., Ferreira I.A.T.M., Gallo G., Glaysher S., Golubchik T., Goncalves S., Hamilton W.L., Harrison E.M., Harvey W.T., Hassan-Ibrahim M.O., Hiscox J.A., Holden M.T.G., Jackson D.K., Jahun A.S., Jesudason N.G., Johnston I., Kemp S.A., Kwiatkowski D.P., Langford C.F., Lawniczak M., Li K.K., Livett R., Loman N.J., Loose M.W., Loveson K.F., Lowe H., Ludden C., Lytras S., Marelli S., Martincorena I., Martinez Nunez R.T., McCann C.M., McHugh M.P., McKenna J.P., McMurray C., Meng B., Mlcochova P., Mohamed A., Moore C., Moses S., Nelson A., Nicholls S.M., Osman H., O’Grady J., Pacchiarini N., Page A.J., Pandey S., Papa G., Parker M.D., Parmar S., Paterson S., Prieto J.A., Pybus O.G., Rambaut A., Robson S.C., Saeed K., Shah R.N., Shepherd J.G., Sillitoe J., Smith C.P., Smith D.L., Snell L.B., Taha Y., Templeton K.E., Thakur N., Thomson E.C., Torok M.E., Underwood A.P., Unnikrishnan M., Volz E.M., Wang D., Watkins J., Young G.R.Fuentes:scopusSARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
ArticleAbstract: Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health response toPalabras claves:Autores:Abraham P., Adams H., Adele S., Afifi S., Asamaphan P., Ash A., Ashraf S., Austin J.A., Azim Ansari M., Barnes E., Barrow M., Beckwith S.M., Beer R., Bernardo M. Gutierrez, Bonsall D., Bresner C., Brown A., Buchan S.L., Cantoni D., Connor T.R., Cowton V., Curran T., Cutino-Moguel T., da Silva Filipe A., Davis C., De Lorenzo G., de Silva T.I., Deeks A.S., Dunachie S.J., Duncan C.J.A., Edgeworth J., Fairley D.J., Fraser C., Fryer H., Fuller W., Furnon W., Golubchik T., Grove J., Guest M., Gunson R., Harvey W.T., Holden M.T.G., Holland P., Hughes J., John M., Jones O., Kele B., Kitchen C., Klenerman P., Koshy C., Kronsteiner B., Logan N., Lythgoe K., Mack A., MacLean O.A., Maksimovic J., Manali M., Mantzouratou A., Marchbank A., McCluggage K., McKenna J.P., Merrick I., Moore S.C., Morgan S., Morriss A., Munn R., Murcia P.R., Murray A., Murray S.M., Nebbia G., Orton R.J., Pascall D.J., Patel A., Patel A.H., Patel B., Payne R.P., Pinto R.M., Price A., Puxty K., Reynolds N., Richter A., Scott S., Shaaban S., Silva V., Singleton D., Smollett K., Southgate J., Spellman K., Szemiel A., Templeton K.E., Thomson L., Tong L., Turtle L., Vink E., Warne B., Whalley T., Wilkie C., Willett B.J., Workman T., Yebra G.Fuentes:scopusSARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2
ArticleAbstract: Background: Since the emergence of SARS-CoV-2, evolutionary pressure has driven large increases in tPalabras claves:covid-19, Delta variant, GENETIC DIVERSITY, mutation, SARS-COV-2, Transmission advantageAutores:Aanensen D.M., Aggarwal D., Amato R., Ariani C.V., Atchison C., Barrett J.C., Bashton M., Beckett A.H., Beckwith S.M., Bernardo M. Gutierrez, Bodinier B., Bonsall D., Bucca G., Bull M., Burns P.J., Byott M., Carabelli A.M., Chand M., Connor T.R., Corden S., Cortes N., Cottrell S., Curran M.D., Darby A.C., De Angelis D., de Oliveira Martins L., de Silva T.I., Eales O., Eastick K., Fairley D.J., Frampton D., Glaysher S., Golubchik T., Goncalves S., Goodfellow I.G., Gunson R.N., Gupta R.K., Hamilton W.L., Harrison E.M., Hassan-Ibrahim M.O., Haw D., Holden M.T.G., Houlihan C., Jackson D.K., Jackson L.M., Johnston I., Jonnerby J., Kwiatkowski D.P., Langford C.F., Levett L.J., Liggett S., Lillie P.J., Livett R., Loman N.J., Loose M.W., Loveson K.F., Ludden C., Lythgoe K., Mahungu T.W., Moore C., Moore N., Moses S., Murray A., Nastouli E., Nebbia G., Nicholls S.M., Nunez R.T.M., Osman H., O’Grady J., Pacchiarini N., Page A.J., Parker M.D., Parmar S., Paterson S., Pope C.F., Prieto J.A., Pybus O.G., Rambaut A., Randell P., Robson S.C., Rogan F., Saeed K., Shepherd J.G., Sheridan L.A., Sillitoe J., Simpson D.A., Singleton D., Smith C.P., Smith D.L., Snell L.B., Templeton K.E., Thomas C., Thomson E.C., Torok M.E., Underwood A.P., Volz E.M., Wang D., Wang H., Watkins J., Williams C., Witney A.A.Fuentes:scopusPublisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (Nature Microbiology, (2022), 7, 8, (1161-1179), 10.1038/s41564-022-01143-7)
OtherAbstract: In the version of this article initially published, the author affiliation information was incompletPalabras claves:Autores:Abraham P., Adams H., Adele S., Afifi S., Asamaphan P., Ash A., Ashraf S., Austin J.A., Azim Ansari M., Barnes E., Barrow M., Beckwith S.M., Beer R., Bernardo M. Gutierrez, Bonsall D., Bresner C., Brown A., Buchan S.L., Cantoni D., Connor T.R., Cowton V., Curran T., Cutino-Moguel T., da Silva Filipe A., Davis C., De Lorenzo G., de Silva T., Deeks A.S., Dunachie S., Dunachie S.J., Duncan C.J.A., Fairley D.J., Fraser C., Fryer H., Fuller W., Furnon W., Golubchik T., Grove J., Guest M., Gunson R.N., Harvey W.T., Holden M.T.G., Holland P., Hughes J., John M., Jones O., Kele B., Kitchen C., Klenerman P., Koshy C., Kronsteiner B., Logan N., Lythgoe K., Mack A., MacLean O.A., Maksimovic J., Manali M., Mantzouratou A., Marchbank A., McCluggage K., McKenna J.P., Merrick I., Moore S.C., Morgan S., Morriss A., Munn R., Murcia P.R., Murray A., Murray S.M., Nebbia G., Orton R.J., Pascall D.J., Patel A., Patel A.H., Patel B., Payne R.P., Pinto R.M., Price A., Puxty K., Reynolds N., Richter A., Scott S., Shaaban S., Silva V., Singleton D., Smollett K., Southgate J., Spellman K., Szemiel A., Templeton K., Thomson L., Tong L., Turtle L., Vink E., Warne B., Whalley T., Wilkie C., Willett B.J., Workman T., Yebra G.Fuentes:scopus